Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg
Clinical trial NCT00529451 · COMPLETED
Trial details
- NCT number
- NCT00529451
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2008-07-01
- Enrollment
- 1613
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.